The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications
Sayeeda Rahman,1 Keerti Singh,2 Sameer Dhingra,3 Jaykaran Charan,4 Paras Sharma,5 Salequl Islam,6 Dilshad Jahan,7 Katia Iskandar,8 Nandeeta Samad,9 Mainul Haque10 1School of Medicine, American University of Integrative Sciences, Bridgetown, Barbados; 2Faculty of Medical Science, The University of th...
Enregistré dans:
Auteurs principaux: | Rahman S, Singh K, Dhingra S, Charan J, Sharma P, Islam S, Jahan D, Iskandar K, Samad N, Haque M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/51d2ea2e008843d28e1ce7d3f68ad4ed |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Costs of medication in older patients: before and after comprehensive geriatric assessment
par: Unutmaz GD, et autres
Publié: (2018) -
Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
par: M. Kurczewska-Michalak, et autres
Publié: (2021) -
Polypharmacy in the HIV-infected older adult population
par: Gleason LJ, et autres
Publié: (2013) -
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
par: Ulrich Bergler, et autres
Publié: (2021) -
Rates, variability, and associated factors of polypharmacy in nursing home patients
par: Beloosesky Y, et autres
Publié: (2013)